Piramal Enterprises has received approval to raise Rs 70.77 crore through 700 Secured, Rated, Listed, Redeemable Principal Protected, Market Linked Non-Convertible Debentures (NCDs) each having a face value of Rs 10 lakh at a further issue price of Rs 10,11,025 per debenture on private placement basis.
These Debentures are proposed to be listed on the Debt Segment and Capital Market Segment of National Stock Exchange of India (NSE) and BSE respectively, and NSE being the designated Stock Exchange. The Board of Directors at its meeting held on July 15, 2022 has approved the same.
Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.